previous compound ID: 1936 next compound
InChIKey: RGCVKNLCSQQDEP-UHFFFAOYSA-N
SMILES: C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "J Goepp" "JW Hanrahan" "R Robert" "DY Thomas" "SD Macknight" "GW Carlile" "B Kus" "D Rotin" "E Matthes"

chemical graph of compound 1936





CID is 4748
synonyms found at PubChem are:
perphenazine, 58-39-9, Perphenazin, Trilafon, Etaperazine, Perfenazine, Ethaperazine, Etaperazin, Fentazin, Perfenazina, Perphenan, Thilatazin, Decentan, Chlorperphenazine, Chlorpiprazine, Emesinal, Tranquisan, Trifaron, Trilifan, Triphenot, F-mon, Perphenazinum, Sch 3940, Perfenil, Perfenazina [Italian], Perfenazina [INN-Spanish], Perphenazinum [INN-Latin], 2-(4-(3-(2-Chloro-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol, UNII-FTA7XXY4EZ, Apo-Perphenazine, C21H26ClN3OS, PZC, NSC 150866, Perphenazine [INN:BAN:JAN], 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol, 4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol, 2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol, HSDB 3379, 1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine, gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine, Perphenazine [Trilafon], FTA7XXY4EZ, Perphenazine maleate, EINECS 200-381-5, CHEMBL567, 2-Chloro-10-3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl phenothiazine, 4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol, 2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol, AI3-50151, MLS000069637, CHEBI:8028, RGCVKNLCSQQDEP-UHFFFAOYSA-N, 1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina, 1-Piperazineethanol, 4-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-, 1-Piperazineethanol, 4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-, 2-Chloro-10-(3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine, 2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine, 2-Chloro-10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazine, SCH-3940, 1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina [Italian], 2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethan-1-ol, NSC150866, CAS-58-39-9, NCGC00015826-02, SMR000058180, 1-Piperazineethanol, 4-(3-(2-chlorophenothiazin-10-yl)propyl)-, 1-(2-Hydroxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine, DSSTox_CID_3441, 2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol, P 6402, DSSTox_RID_77031, DSSTox_GSID_23441, 1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, 2-Chloro-10-3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl phenothiazine, Piperazineethanol, 4-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-, 2-{4-[3-(2-Chloro-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol, gamma-[4-(beta-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine, SR-01000000137, perphanzine, 2-{4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazinyl}ethan-1-ol, Piperazineethanol, 4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-, .gamma.-(4-(.beta.-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine, .gamma.-[4-(.beta.-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine, 2-(4-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethan-1-ol, Perphenazine [USP:INN:BAN:JAN], Prestwick_536, Triavil (TN), Siquil (TN), Etrafon (Salt/Mix), Spectrum_001610, 1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, trihydrochloride, AC1L1IVB, Opera_ID_1161, Prestwick0_000125, Prestwick1_000125, Prestwick2_000125, Prestwick3_000125, Spectrum2_001602, Spectrum3_000758, Spectrum4_000843, Spectrum5_001493, Lopac-P-6402, D02HED, Lopac0_000930, Oprea1_603835, REGID_for_CID_4748, SCHEMBL42125, BSPBio_000170, BSPBio_002376, GTPL209, KBioGR_001445, KBioSS_002090, MLS001146929, MLS002548897, BIDD:GT0150, DivK1c_000880, SPECTRUM1503934, SPBio_001603, SPBio_002109, BPBio1_000188, DTXSID1023441, component of Triavil (Salt/Mix), CTK8G2334, HMS502L22, KBio1_000880, KBio2_002090, KBio2_004658, KBio2_007226, KBio3_001596, Perphenazine (JP15/USP/INN), Perphenazine (JP17/USP/INN), AOB5376, MolPort-001-727-942, NINDS_000880, HMS1568I12, HMS1922M14, HMS2093M15, HMS2095I12, HMS2232D21, HMS3259C09, HMS3262J22, HMS3370O14, HMS3712I12, Pharmakon1600-01503934, HY-A0077, KS-000017RJ, Perphenazine 1.0 mg/ml in Methanol, Tox21_110233, Tox21_500930, 1-Piperazineethanol, trihydrochloride, BDBM50130273, CCG-39060, MFCD00056798, NSC758649, s4731, SBB037866, STK019818, ZINC19228902, AKOS000664046, Tox21_110233_1, CS-5137, DB00850, KS-5105, LP00930, MCULE-6019566915, NC00472, NE42348, NSC-150866, NSC-758649, IDI1_000880, MRF-0000509, NCGC00015826-01, NCGC00015826-03, NCGC00015826-04, NCGC00015826-05, NCGC00015826-06, NCGC00015826-07, NCGC00015826-08, NCGC00015826-09, NCGC00015826-10, NCGC00015826-13, NCGC00024092-03, NCGC00024092-04, NCGC00024092-05, NCGC00024092-06, NCGC00261615-01, AC-12196, AJ-72574, BAS 00139131, BC204191, CPD000058180, SAM002264637, SC-89514, ST079662, SBI-0050904.P003, AB0010670, KB-222063, LS-112185, AB00052390, EU-0072164, EU-0100930, FT-0603244, P1970, ST24039354, 1446-EP2272537A2, 1446-EP2298776A1, C07427, D00503, J10210, AB00052390_17, A831863, L000919, I06-1508, SR-01000000137-2, SR-01000000137-4, SR-01000000137-5, SR-01000000137-8, W-105390, BRD-K10995081-001-05-5, BRD-K10995081-001-15-4, WLN: T C666 BN ISJ EG B3- AT6N DNTJ D2Q, Z1945707494, Perphenazine, British Pharmacopoeia (BP) Reference Standard, Perphenazine, European Pharmacopoeia (EP) Reference Standard, 2-[4-[3-(2-chloro-10-phenothiazinyl)propyl]-1-piperazinyl]ethanol, Perphenazine, United States Pharmacopeia (USP) Reference Standard, 2-[4-[3-(2-chloranylphenothiazin-10-yl)propyl]piperazin-1-yl]ethanol, 2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]-piperazin-1-yl]ethanol, 2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol #, Perphenazine for system suitability, European Pharmacopoeia (EP) Reference Standard